Earnings6 reported quarters · next on Feb 23, 2027
Earnings
Quarter
EPS
EPS expected
Revenue
Revenue expected
Result
Q3 FY2026reported Nov 5, 2026
$1.72
$1.89
$908.6M
$934.3M
EPS missRevenue miss
Q2 FY2026reported Aug 5, 2026
$1.88
$1.84
$904.4M
$876.4M
EPS beatRevenue beat
Q1 FY2026reported May 6, 2026
$1.61
$1.60
$807.3M
$780.7M
EPS in lineRevenue beat
Q4 FY2025reported Feb 24, 2026
$2.15
$1.60
$796.7M
$755.6M
EPS beatRevenue beat
Q3 FY2025reported Nov 4, 2025
$1.17
$1.52
$710.6M
$704.8M
EPS missRevenue in line
Q2 FY2025reported Aug 4, 2025
$2.12
$1.45
$668.5M
$641.0M
EPS beatRevenue beat
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Each firm's latest price target on AXON, newest first
Firm
Rating
Target
Action
Date
Northland Capital Markets
Not stated
$540
Target set
RBC Capital
Outperform
$615
Cut from $735
Piper Sandler
Overweightrated Oct 20, 2026
$540
Cut from $561
Needham
Not stated
$500
Cut from $750
Raymond James
Not stated
$675
Target set
Argus
Buy
$600
Target set
Morgan Stanley
Overweight
$640
Raised from $600
Goldman Sachs
Not stated
$715
Raised from $535
Barclays
Overweight
$688
Raised from $523
UBS
Neutral
$440
Target set
Baird
Not stated
$800
Target set
Craig-Hallum
Not stated
$820
Target set
Northcoast
Buy
$742
Target set
Each firm's latest target from the past year, with the rating stated with its note. These are the firms' own views, not GetSignal's, and we do not endorse them. Not investment advice. A rating with its own date under it is the firm's latest from the past 120 days, where the note stated none.
3 other firms rated AXON in the past year with no current target listed here. Ratings and targets come from licensed market data providers. A target is listed only after its firm and company are confirmed against a report of the note. As of Nov 11, 2026.
Cameron Brooks’s pay came to $1.3M for fiscal 2025.
Executive
Salary
Stock awards
Other
Total
Cameron BrooksChief Revenue Officer
$419K
$0
$893K
$1.3M
Brittany BagleyChief Operating Officer and Chief Financial Officer
$450K
$0
$845K
$1.3M
Jeffrey KuninsChief Product Officer and Chief Technology Officer
$350K
$0
$514K
$864K
Joshua IsnerPresident
$125K
$0
$603K
$728K
Patrick SmithChief Executive Officer
$31K
$0
$9K
$40K
The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. Executives who have since left are not shown. Read the filing
13F filings13F positions as of Jun 30, 2026
Institutional holders
Holder
Value
Shares
Shares vs prior qtr
% of shares out
BlackRock, Inc.
$4.7B
8,334,551
+4.3%
10.37%
Vanguard Capital Management LLC
$2.9B
5,130,199
+1.7%
6.38%
State Street Corp
$2.2B
3,885,570
+5.5%
4.85%
Vanguard Portfolio Management LLC
$2.1B
3,684,814
+2.2%
4.59%
Invesco Ltd.
$1.8B
3,229,060
+91.4%
4.02%
Baillie Gifford & Co
$1.7B
3,059,487
+24.4%
3.81%
FMR LLC
$1.7B
3,024,957
+26.2%
3.76%
Geode Capital Management, LLC
$1.3B
2,312,765
+2.5%
2.88%
Wellington Management Group LLP
$1.2B
2,103,142
-13.0%
2.62%
T. Rowe Price Associates, Inc.
$1.0B
1,871,812
+137.3%
2.33%
Westfield Capital Management Co LP
$836.1M
1,491,490
+40.2%
1.86%
Sands Capital Management, LLC
$830.2M
1,480,817
-5.3%
1.84%
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. Scheduled: set up in advance under a Rule 10b5-1 trading plan. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.
Other Form 4 activity (16)
Insider
Event
Shares
Date
Cameron BrooksChief Revenue Officer
Tax withholding
5,850
Oct 1, 2026
Isaiah FieldsChief Legal Officer
Tax withholding
763
Aug 31, 2026
Elizabeth Reid CoughlinChief Human Officer
Tax withholding
479
Aug 31, 2026
Cameron BrooksChief Revenue Officer
Tax withholding
735
Aug 31, 2026
Jennifer H. MakChief Accounting Officer
Tax withholding
156
Aug 31, 2026
Patrick W. SmithChief Executive Officer
Stock award
97,015
Aug 16, 2026
Cameron BrooksChief Revenue Officer
Stock award
15,810
Aug 16, 2026
Isaiah FieldsChief Legal Officer
Stock award
10,488
Aug 16, 2026
Elizabeth Reid CoughlinChief Human Officer
Stock award
6,818
Aug 16, 2026
Jennifer H. MakChief Accounting Officer
Stock award
3,906
Aug 16, 2026
Brittany BagleyCOO & CFO
Tax withholding
8,708
Aug 13, 2026
Brittany BagleyCOO & CFO
Stock award
30,560
Aug 16, 2026
Joshua IsnerPresident
Tax withholding
15,704
Aug 13, 2026
Joshua IsnerPresident
Stock award
82,128
Aug 16, 2026
Jeffrey C. KuninsCPO & CTO
Tax withholding
6,233
Aug 13, 2026
Jeffrey C. KuninsCPO & CTO
Stock award
24,371
Aug 16, 2026
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
STOCK Act8 disclosures of 9 on record · median 34d of the 45 allowed
Congress trades in AXON
Since the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.
+41.8%since the saleEstimated exit price $213.33, close on Tue Oct 24, 2023Current price $302.54, close on Tue Nov 10
Oct 24, 2023
Nov 9, 2023
16d
Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it. On an option line the prices are the stock's, never the option's: the premium is never disclosed.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no prices or move are shown for that row.
A further member reports a position estimated under $1,000; that member is not listed.
The largest estimated position is in the $15,001 - $50,000 band. Estimate, as of Nov 11, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, marked to the latest close we hold. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
On Form 4, code P is an open-market purchase and S an open-market sale; a sale marked scheduled was set up in advance under a Rule 10b5-1 plan. Awards, option exercises, tax withholding and gifts (A, M, F and G) are listed under Other Form 4 activity and never counted as either.
A STOCK Act disclosure gives each trade as a band of dollar values, which we do not narrow, and is due within 45 days of the trade. An option is described by its underlying company's name; its row says it is an option.
What the filings on AXON show and how current they are.
Are insiders buying or selling AXON?
Across the 5 most recent open-market filings shown here, 0 were purchases and 5 were sales. 5 were scheduled in advance under a Rule 10b5-1 plan.
Which members of Congress have traded AXON?
Alan Armstrong, Jefferson Shreve, Robert Bresnahan, Markwayne Mullin and Greg Stanton disclosed AXON transactions in the filings shown here.
Which members of Congress hold AXON?
2 members of Congress report a position of $1,000 or more in AXON in the estimate we hold as of Nov 11, 2026. The estimated positions of $1,000 or more belong to Robert Bresnahan and Gilbert Ray Cisneros, Jr. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is AXON in the S&P 500 or the Nasdaq 100?
Axon Enterprise, Inc. is a current member of the S&P 500 and Nasdaq 100, per the membership list we hold as of Nov 11, 2026. Current members of either index get a page here whatever their filing history.
How quickly are AXON trades disclosed?
Insider filings on this page reached the public a median of 2 business days after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows. Congressional disclosures took a median of 34 days, against the 45 the STOCK Act allows.